Premium
Sutro Biopharma Inc (STRO)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated ce... Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Show more
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Boehringer Ingelheim BioXcellence™ and Sutro Biopharma Inc. today announced that they successfully applied Sutro’s proprietary...
- 32% objective response rate (ORR) in evaluable patients at the 5.2 mg/kg starting dose – the selected dose for randomized portion (Part 2) of ongoing registrational REFRαME-O1 trial - - These...
- Expects to deliver three Investigational New Drug (IND) applications in next three years based on next-generation ADC technology - - Two new clinical trials, REFRαME-P1, a registration-enabling...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.16 | 8.51063829787 | 1.88 | 2.08 | 1.84 | 974104 | 1.99415165 | CS |
| 4 | 0.06 | 3.0303030303 | 1.98 | 2.15 | 1.67 | 862276 | 1.90942625 | CS |
| 12 | -1.31 | -39.1044776119 | 3.35 | 4.6 | 1.67 | 1080228 | 2.46285037 | CS |
| 26 | -1.81 | -47.012987013 | 3.85 | 5.17 | 1.67 | 798580 | 3.05444785 | CS |
| 52 | -2.77 | -57.5883575884 | 4.81 | 6.13 | 1.67 | 844348 | 3.67314567 | CS |
| 156 | -7.8 | -79.2682926829 | 9.84 | 10.98 | 1.67 | 667736 | 4.69561271 | CS |
| 260 | -9.7 | -82.6235093697 | 11.74 | 28.3 | 1.67 | 533286 | 7.97224245 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
